Revenue | ₹496.63Cr |
Net Profits | ₹58.25Cr |
Net Profit Margins | 11.73% |
Astrazeneca Pharma India Ltd’s revenue jumped 26.74% since last year same period to ₹496.63Cr in the Q4 2024-2025. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated 10.79% jump in its revenue since last 3-months.
Astrazeneca Pharma India Ltd’s net profit jumped 47.54% since last year same period to ₹58.25Cr in the Q4 2024-2025. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated 88.82% jump in its net profits since last 3-months.
Astrazeneca Pharma India Ltd’s net profit margin jumped 16.42% since last year same period to 11.73% in the Q4 2024-2025. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated 70.43% jumped in its net profit margins since last 3-months.
The revenue for Astrazeneca Pharma India Ltd in the Q4 results 2024 was ₹496.63Cr.
The net profit for Astrazeneca Pharma India Ltd in the Q4 results 2024 was ₹58.25Cr.
The net profit margin for Astrazeneca Pharma India Ltd in the Q4 results 2024 was 11.73%.
The revenue for Astrazeneca Pharma India Ltd in the Q4 results 2023 was ₹391.86Cr.
The net profit for Astrazeneca Pharma India Ltd in the Q4 results 2023 was ₹39.48Cr.
The net profit margin for Astrazeneca Pharma India Ltd in the Q4 results 2023 was 10.08%.